Laplace Partners
Overview
Laplace Partners is a venture capital firm based in Seoul, South Korea, that invests in early-stage technology companies, with a focus on sectors including biopharmaceuticals, AI, diagnostics, medical devices, and digital health.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nano Solution | Jun 2025 | VC Round | Lead |
| Arbormed | Jul 2024 | Series C | Lead |
| Ingenium Therapeutics | Nov 2023 | Series A | Co-investor |
| EFIL BioScience | Oct 2021 | Seed | Co-investor |
| CoBX Bio | Sep 2025 | Pre Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Susanna Maly
Venture Capital Associate
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Laplace Partners based?
Laplace Partners is headquartered in Seoul, South Korea.
When was Laplace Partners founded?
Laplace Partners was founded in 2020.
How many portfolio companies does Laplace Partners have?
Laplace Partners has 6 portfolio companies in Caplight's dataset.
What are some companies in Laplace Partners's portfolio?
Portfolio companies visible on Caplight include Nano Solution, Arbormed, Ingenium Therapeutics, EFIL BioScience, CoBX Bio.
What was Laplace Partners's most recent investment shown here?
Laplace Partners's most recent investment in this portfolio sample was in CoBX Bio in 2025.
What sectors does Laplace Partners focus on?
Laplace Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Consumer & Commerce.
What company stages does Laplace Partners focus on?
Stage focus information for Laplace Partners is not publicly available.
What is Laplace Partners's AUM?
Laplace Partners's assets under management are estimated between $8.7M and $8.7M.